Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial

Further Publications

Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study

Lancet Respir Med.

Warnecke G, Van Raemdonck D, Smith MA, Massard G, Kukreja J, Rea F, Loor G, De Robertis F, Nagendran J, Dhital KK, Moradiellos Díez FJ, Knosalla C, Bermudez CA, Tsui S, McCurry K, Wang IW, Deuse T, Lesèche G, Thomas P, Tudorache I, Kühn C, Avsar M, Wiegmann B, Sommer W, Neyrinck A, Schiavon M, Calebrese F, Santelmo N, Olland A, Falcoz PE, Simon AR, Varela A, Madsen JC, Hertz M, Haverich A, Ardehali A

doi: 10.1016/S2213-2600

PHARMA NEWS

Interstitial Lung Disease

Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD¹

doi: 10.1056/NEJMoa1903076

RECOMMENDED

Lung Cancer

A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non-Small Cell Lung Cancer

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Clin Lung Cancer

Mattes MD, Eubank TD, Almubarak M, Wen S, Marano GD, Jacobson GM, Ma PC

doi: 10.1016/j.cllc.2021.01.012

RECOMMENDED

Further Publications

Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry

★ 1 Recommended by Dr Martin Frey, Faculty Member

J Heart Lung Transplant.

Van Raemdonck D, Keshavjee S, Levvey B, Cherikh WS, Snell G, Erasmus M, Simon A, Glanville AR, Clark S, D'Ovidio F, Catarino P, McCurry K, Hertz MI, Venkateswaran R, Hopkins P, Inci I, Walia R, Kreisel D, Mascaro J, Dilling DF, Camp P, Mason D, Musk M, Burch M, Fisher A, Yusen RD, Stehlik J, Cypel M, International Society for Heart and Lung Transplantation.

doi: 10.1016/j.healun.2019.09.007.

RECOMMENDED

Further Publications

Effect of Lung Protective Ventilation in Organ Donors on Lung Procurement and Recipient Survival

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

doi: 10.1164/rccm.201910-2067OC.

RECOMMENDED

Further Publications

Transplantation experience as a predictor for quality of life during the first 6 months after lung transplantation

Clin Transplant.

Goetzmann L, Seiler A, Benden C, Boehler A, Büchi S, Jenewein J, Ruettner B, Mueller-Alcazar A, Weierstall R

doi: 10.1111/ctr.13393.

Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study

Eur Respir J.

Benmerad M, Slama R, Botturi K, Claustre J, Roux A, Sage E, Reynaud-Gaubert M, Gomez C, Kessler R, Brugière O, Mornex JF, Mussot S, Dahan M, Boussaud V, Danner-Boucher I, Dromer C, Knoop C, Auffray A, Lepeule J, Malherbe L, Meleux F, Nicod L, Magnan A, Pison C, Siroux V; SysCLAD consortium

doi: 10.1183/

ARDS

High-Frequency Oscillatory Ventilation Use and Severe Pediatric ARDS in the Pediatric Hematopoietic Cell Transplant Recipient

Respir Care.

Rowan CM, Loomis A, McArthur J, Smith LS, Gertz SJ, Fitzgerald JC, Nitu ME, Moser EA, Hsing DD, Duncan CN, Mahadeo KM, Moffet J, Hall MW, Pinos EL, Tamburro RF, Cheifetz IM

doi: 10.4187/respcare.05765.

RECOMMENDED

COPD

Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated COPD Patients (CLAIM): A Double-Blind, Randomised, Crossover Trial

Am J Respir Crit Care Med.

Vogel-Claussen J, Schönfeld CO, Kaireit TF, Voskrebenzev A, Czerner CP, Renne J, Tillmann HC, Berschneider K, Hiltl S, Bauersachs J, Welte T, Hohlfeld JM

doi: 10.1164/rccm.

Related content

Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study

Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD1

A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non-Small Cell Lung Cancer

Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry

Effect of Lung Protective Ventilation in Organ Donors on Lung Procurement and Recipient Survival

Transplantation experience as a predictor for quality of life during the first 6 months after lung transplantation

Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study

High-Frequency Oscillatory Ventilation Use and Severe Pediatric ARDS in the Pediatric Hematopoietic Cell Transplant Recipient

Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated COPD Patients (CLAIM): A Double-Blind, Randomised, Crossover Trial

Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD¹